China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China
· Delayed Price · Currency is CNY 30.00
-0.07 (-0.23%)
Mar 10, 2026, 11:15 AM CST
SHE:000999 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 50,043 | 47,364 | 56,946 | 49,142 | 46,264 | 33,518 | Upgrade
|
| Market Cap Growth | -11.08% | -16.83% | 15.88% | 6.22% | 38.03% | 37.29% | Upgrade
|
| Enterprise Value | 63,221 | 60,542 | 56,320 | 49,886 | 41,955 | 29,968 | Upgrade
|
| Last Close Price | 30.07 | 28.46 | 33.33 | 27.44 | 25.41 | 18.18 | Upgrade
|
| PE Ratio | 14.60 | 13.84 | 16.91 | 17.23 | 18.89 | 16.31 | Upgrade
|
| Forward PE | 13.39 | 9.40 | 16.06 | 23.84 | 21.67 | 23.31 | Upgrade
|
| PS Ratio | 1.58 | 1.50 | 2.06 | 1.99 | 2.56 | 2.16 | Upgrade
|
| PB Ratio | 1.34 | 1.27 | 2.26 | 2.03 | 2.64 | 2.13 | Upgrade
|
| P/TBV Ratio | 6.08 | 5.75 | 5.00 | 4.73 | 4.35 | 3.74 | Upgrade
|
| P/FCF Ratio | - | - | 15.77 | 14.74 | 22.52 | 33.12 | Upgrade
|
| P/OCF Ratio | - | - | 12.94 | 11.72 | 15.39 | 17.78 | Upgrade
|
| PEG Ratio | - | 1.36 | 1.36 | 1.36 | 1.36 | 1.36 | Upgrade
|
| EV/Sales Ratio | 2.00 | 1.91 | 2.04 | 2.02 | 2.32 | 1.93 | Upgrade
|
| EV/EBITDA Ratio | 11.52 | 11.04 | 11.66 | 11.80 | 12.91 | 11.34 | Upgrade
|
| EV/EBIT Ratio | 13.04 | 12.49 | 13.44 | 14.08 | 15.07 | 13.54 | Upgrade
|
| EV/FCF Ratio | - | - | 15.59 | 14.96 | 20.42 | 29.61 | Upgrade
|
| Debt / Equity Ratio | 0.15 | 0.15 | 0.05 | 0.12 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 1.00 | 1.00 | 0.26 | 0.69 | 0.12 | 0.09 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.36 | 0.90 | 0.19 | 0.23 | Upgrade
|
| Net Debt / Equity Ratio | -0.08 | -0.08 | -0.21 | -0.22 | -0.16 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.56 | -0.56 | -1.12 | -1.24 | -0.85 | -1.53 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -1.50 | -1.57 | -1.34 | -4.00 | Upgrade
|
| Asset Turnover | - | - | 0.69 | 0.74 | 0.70 | 0.67 | Upgrade
|
| Inventory Turnover | - | - | 2.68 | 3.07 | 3.43 | 3.18 | Upgrade
|
| Quick Ratio | - | - | 1.15 | 1.25 | 1.02 | 1.23 | Upgrade
|
| Current Ratio | - | - | 1.61 | 1.74 | 1.38 | 1.60 | Upgrade
|
| Return on Equity (ROE) | 10.93% | 10.93% | 15.26% | 15.19% | 14.99% | 14.07% | Upgrade
|
| Return on Assets (ROA) | - | - | 6.53% | 6.58% | 6.73% | 5.94% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.95% | 12.61% | 17.73% | 17.72% | 17.71% | 17.45% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 15.80% | 13.00% | 15.10% | 13.30% | Upgrade
|
| Earnings Yield | 6.84% | 7.22% | 5.91% | 5.80% | 5.29% | 6.13% | Upgrade
|
| FCF Yield | - | - | 6.34% | 6.78% | 4.44% | 3.02% | Upgrade
|
| Dividend Yield | 2.32% | - | 3.05% | 3.23% | 2.33% | 2.77% | Upgrade
|
| Payout Ratio | - | - | 84.16% | 37.01% | 34.95% | 24.61% | Upgrade
|
| Buyback Yield / Dilution | 0.22% | 0.22% | -0.10% | 0.33% | -0.90% | 0.15% | Upgrade
|
| Total Shareholder Return | 2.54% | 0.22% | 2.95% | 3.57% | 1.43% | 2.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.